Scientists, researchers, practicing veterinarians, animal health companies and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.
Boehringer Ingelheim provides five $15,000 awards annually to researchers whose proposals help to advance the diagnosis, treatment and understanding of equine infectious disease(s).
Veterinarians, diagnosticians and public and private researchers in North America are eligible to submit proposals for research programs that advance diagnosis, treatment and understanding of equine infectious disease(s). Residents and DVM/VMD graduate students will be given preferential consideration for two of the five grants if proposals are deemed adequate merit.
Veterinarians, diagnosticians and public and private researchers in North America are eligible to submit proposals for research programs that advance diagnosis, treatment and understanding of equine infectious disease(s). Residents and DVM/VMD graduate students will be given preferential consideration for two of the five grants if proposals are deemed adequate merit.
The deadline for proposals for the 2023 Advancement in Equine Research Award is: September 15, 2023.
Objectives
Research Focus
The 2023 research topic Equine Respiratory Disease with suggested areas of research focused on:
Eligibility
Eligibility for participation to include anyone in United States, Canada and Mexico.
Basic Requirements
Selection Criteria
The Advancement in Equine Research Review Board acting on its own, without influence from the sponsoring company, will peer review and select proposals based on the following criteria:
The Advancement in Equine Research Review Board Members
The independent Review Board has revolving seats to ensure the Board remains impartial and infused with new ideas. The renowned members consist of equine industry professionals including practicing veterinarians and researchers.
Confidentiality of Proposals
Board Member Conflict of Interest
The Board members will not participate in the review and evaluation of any proposals or subsequent manuscripts for which they are investigators or authors, respectively.
Application Procedure
Please visit the full proposal instructions page for more details, and to download application forms. All proposals must comply with application instructions and be submitted via e-mail to steve.grubbs@boehringer-ingelheim.com.